Barinthus Biotherapeutics plc
BRNS
$0.68
-$0.04-5.71%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.90% | -12.97% | -10.43% | 4.30% | -9.91% |
| Total Receivables | -2.37% | 29.97% | -45.97% | -66.04% | 271.06% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.77% | 26.72% | -14.47% | -17.06% | -9.59% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -21.10% | 47.26% | -8.93% | 348.71% | -25.88% |
| Total Current Assets | -13.58% | -8.62% | -12.61% | -6.62% | 2.10% |
|
|
|||||
| Total Current Assets | -13.58% | -8.62% | -12.61% | -6.62% | 2.10% |
| Net Property, Plant & Equipment | -16.01% | -22.07% | -14.47% | -35.27% | -0.47% |
| Long-term Investments | -- | -- | -- | -- | 0.00% |
| Goodwill | -- | -- | -- | -- | 0.00% |
| Total Other Intangibles | -26.79% | -3.73% | -3.60% | -3.47% | -3.36% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.59% | 4.66% | 2.38% | -4.86% | 4.51% |
| Total Assets | -15.71% | -8.76% | -11.43% | -15.03% | 1.04% |
|
|
|||||
| Total Accounts Payable | -61.22% | 32.65% | -45.15% | -19.57% | 20.34% |
| Total Accrued Expenses | -9.27% | 2.31% | -24.43% | 19.57% | -22.49% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.93% | 3.88% | 2.08% | -3.32% | 3.65% |
| Total Finance Division Other Current Liabilities | -8.07% | 4.38% | -15.94% | -14.97% | 143.62% |
| Total Other Current Liabilities | -8.07% | 4.38% | -15.94% | -14.97% | 143.62% |
| Total Current Liabilities | -15.14% | 6.25% | -23.51% | 3.88% | -3.32% |
|
|
|||||
| Total Current Liabilities | -15.14% | 6.25% | -23.51% | 3.88% | -3.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -4.01% | -0.07% | -1.27% | -5.58% | 0.27% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.59% | -1.45% | 0.45% | 28.07% | -6.54% |
| Total Liabilities | -9.01% | 2.56% | -12.55% | 3.30% | -2.44% |
|
|
|||||
| Common Stock & APIC | -0.11% | -0.07% | 0.12% | 0.41% | 0.41% |
| Retained Earnings | -5.23% | -8.21% | -8.27% | -9.46% | -3.88% |
| Treasury Stock & Other | -22.81% | 39.21% | 18.01% | -66.71% | 37.25% |
| Total Common Equity | -17.50% | -11.36% | -11.18% | -18.37% | 1.71% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.50% | -11.36% | -11.18% | -18.37% | 1.71% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -7.69% | 5.05% | -6.60% | -36.53% | -2.91% |
| Total Equity | -17.49% | -11.34% | -11.17% | -18.39% | 1.70% |
|
|
|||||